2m 2m 2m 2m 2m 2m 2m
TRANSCODE THERA (RNAZ)
NASDAQ
$3.05+$0.18 (+6.41%)
Price as of Aug 21, 2026 7:56 PM EDT- $3.0MMarket Cap
- -72.03%1-Year Change
- BiotechnologyIndustry
TRANSCODE THERA (RNAZ)
$3.05+$0.18 (+6.41%)
RNAZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.87 | ||
Change | -$0.10 (-3.37%) | ||
Open | $2.90 | ||
High | $3.00 | ||
Low | $2.87 | ||
Previous Close | $2.97 | ||
Volume | 42,178 | ||
30-Day Average Volume | 28,331 | ||
1-Week Change | -12.50% | ||
1-Month Change | -65.83% | ||
1-Year Change | -72.03% | ||
3-Year Change | -100.00% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 1.1M | ||
Total Assets | $151.0M | ||
Market Cap | $3.0M | ||
Enterprise Value | -$4.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.8M | ||
Free Cash Flow | -$5.4M | ||
EBIT | -$6.7M | ||
EBITDA | -$6.7M | ||
Net Working Capital | $5.2M | ||
EPS | -$7.17 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -0 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 28 | ||
Last Split Date | 05/15/2025 | ||
Earnings & Revenue